Trifluoperazine dihydrochloride
An antiadrenergic, antidopaminergic and anticholinergic agent; is identified as an inhibitor that disrupts the S100A4/myosin-IIA interaction; block S100A4-mediated disassembly of myosin-IIA filaments, and promote S100A4 oligomerization.Schizophrenia Approved (In Vitro) :Trifluoperazine dihydrochloride is a long-established, widely used 'conventional' antipsychotic agent. Trifluoperazine dihydrochloride has been an extensively studied drug molecule that has been used as a calmodulin inhibitor.Trifluoperazine dihydrochloride acts as a reversible inhibitor of influenza virus morphogenesis, but not budding, by disturbing cellular CaM and/or CaM-dependent functions.
Product Specifications
CAS Number
440-17-5
Product Name Alternative
TFP | SKF5019
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
FC (C (C=C1N2CCCN3CCN (C) CC3) =CC=C1SC4=C2C=CC=C4) (F) F.[H]Cl.[H]Cl
Molecular Formula
C21H26Cl2F3N3S
Molecular Weight
480.4174
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
10H-Phenothiazine, 10-[3- (4-methyl-1-piperazinyl) propyl]-2- (trifluoromethyl) -, hydrochloride (1:2)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MC1R (MC1R, CMM5, MC1 Receptor, MC1-R, MSHR, Melanocortin Receptor 1, Melanotropin Receptor, Melanocortin 1 Receptor, MSH-R, SHEP2) discontinued
Phospho-VEGF Receptor 2 (Tyr1175) polyclonal antibody
Phospho-VEGF Receptor 2 (Tyr1175) polyclonal antibody
